Morphine causes distinct changes in the lipidome throughout the brain and body after acute or chronic administration: implications for novel endogenous lipid signaling systems involved in opioid reward and withdrawal

A recent study has uncovered significant alterations in the lipidome across various parts of the brain and body following both acute and chronic administration of morphine. These changes may hold the key to novel endogenous lipid signaling systems involved in the rewarding and withdrawal aspects of opioid use. While prior research has primarily focused on the endocannabinoid system, this investigation sheds light on alternative lipid signaling pathways that could offer new therapeutic targets for opioid use disorder (OUD).

The researchers conducted two experiments: an acute paradigm (30 minutes post-injection of 20mg/kg morphine) and a chronic paradigm (5 days, twice daily dosing with escalating morphine doses of 20mg to 100mg/kg). They analyzed 100 targeted endolipids in eight brain regions, plasma, liver, and feces in male mice. In the acute condition, the striatum exhibited the highest change rate (42%), while the thalamus showed the least change (19%).

In the chronic condition, plasma endolipids were notably altered in 79% of cases, with the cortex showing the most significant change (39%).

Among the most dynamic changes were the levels of N-acyl GABAs, N-acyl valines, N-acyl taurines, and specific bile acids such as DCA and TCA. Interestingly, the levels of anandamide (AEA) and 2-arachidonoylglycerol (2-AG), two primary endocannabinoid ligands, remained largely unchanged. These findings suggest that morphine use dysregulates a wide range of endolipid biosynthesis and metabolism, particularly in signaling ligands.

This altered lipidome may contribute to the unwanted side effects of opioids, including dependence and withdrawal.

These results provide valuable insights into previously unexplored endolipid signaling pathways that could be targeted for therapeutic interventions in OUD. By understanding these unique changes in response to morphine, researchers can potentially develop novel treatments that address the physiological alterations associated with opioid use.